Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo C Maley

Showing results (91-100 of 135) with videos related to

Pageof 14
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 16, 2006
Genetic mechanisms of TP53 loss of heterozygosity in Barrett's esophagus: implications for biomarker validationV Jon Wongsurawat, Jennifer C Finley, Patricia C Galipeau, et al.
Molecular Cancer Research : MCR|July 22, 2010
Deletion at fragile sites is a common and early event in Barrett's esophagusLisa A Lai, Rumen Kostadinov, Michael T Barrett, et al.
Biorxiv : the Preprint Server for Biology|October 2, 2023
Testing Adaptive Therapy Protocols using Gemcitabine and Capecitabine on a Mouse Model of Endocrine-Resistant Breast CancerSareh Seyedi, Ruthanne Teo, Luke Foster, et al.
Breast Cancer Research : BCR|March 22, 2025
Evolutionary measures show that recurrence of DCIS is distinct from progression to breast cancerAngelo Fortunato, Diego Mallo, Luis Cisneros, et al.
Medrxiv : the Preprint Server for Health Sciences|August 26, 2024
Evolutionary Measures Show that Recurrence of DCIS is Distinct from Progression to Breast CancerAngelo Fortunato, Diego Mallo, Luis Cisneros, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2026
Does Fermentation Enhance Beverage Safety? Kombucha's Resistance to Microbial Invasion Suggests a Protective RoleGissel Marquez Alcaraz, Shrinath Narayanan, Joe Alcock, et al.
Plos One|June 29, 2023
Is chimerism associated with cancer across the tree of life?Stefania E Kapsetaki, Angelo Fortunato, Zachary Compton, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 2, 2015
Assessment of Esophageal Adenocarcinoma Risk Using Somatic Chromosome Alterations in Longitudinal Samples in Barrett's EsophagusXiaohong Li, Thomas G Paulson, Patricia C Galipeau, et al.
Cancers|January 23, 2024
Testing Adaptive Therapy Protocols Using Gemcitabine and Capecitabine in a Preclinical Model of Endocrine-Resistant Breast CancerSareh Seyedi, Ruthanne Teo, Luke Foster, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2006
Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: a prospective analysisDennis L Chao, Carlo C Maley, Xifeng Wu, et al.
Pageof 14

Showing results (91-100 of 135) with videos related to

Sort By:
Pageof 14
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 16, 2006
Genetic mechanisms of TP53 loss of heterozygosity in Barrett's esophagus: implications for biomarker validationV Jon Wongsurawat, Jennifer C Finley, Patricia C Galipeau, et al.
Molecular Cancer Research : MCR|July 22, 2010
Deletion at fragile sites is a common and early event in Barrett's esophagusLisa A Lai, Rumen Kostadinov, Michael T Barrett, et al.
Biorxiv : the Preprint Server for Biology|October 2, 2023
Testing Adaptive Therapy Protocols using Gemcitabine and Capecitabine on a Mouse Model of Endocrine-Resistant Breast CancerSareh Seyedi, Ruthanne Teo, Luke Foster, et al.
Breast Cancer Research : BCR|March 22, 2025
Evolutionary measures show that recurrence of DCIS is distinct from progression to breast cancerAngelo Fortunato, Diego Mallo, Luis Cisneros, et al.
Medrxiv : the Preprint Server for Health Sciences|August 26, 2024
Evolutionary Measures Show that Recurrence of DCIS is Distinct from Progression to Breast CancerAngelo Fortunato, Diego Mallo, Luis Cisneros, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2026
Does Fermentation Enhance Beverage Safety? Kombucha's Resistance to Microbial Invasion Suggests a Protective RoleGissel Marquez Alcaraz, Shrinath Narayanan, Joe Alcock, et al.
Plos One|June 29, 2023
Is chimerism associated with cancer across the tree of life?Stefania E Kapsetaki, Angelo Fortunato, Zachary Compton, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 2, 2015
Assessment of Esophageal Adenocarcinoma Risk Using Somatic Chromosome Alterations in Longitudinal Samples in Barrett's EsophagusXiaohong Li, Thomas G Paulson, Patricia C Galipeau, et al.
Cancers|January 23, 2024
Testing Adaptive Therapy Protocols Using Gemcitabine and Capecitabine in a Preclinical Model of Endocrine-Resistant Breast CancerSareh Seyedi, Ruthanne Teo, Luke Foster, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2006
Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: a prospective analysisDennis L Chao, Carlo C Maley, Xifeng Wu, et al.
Pageof 14